(Q40284261)

19 September 2017

title

Fusion of CpG-ODN-stimulating dendritic cells with Lewis lung cancer cells can enhance anti-tumor immune responses (English)

1 reference

19 September 2017

1 reference

Du YC

1

1 reference

19 September 2017

Lin P

2

1 reference

19 September 2017

Zhang J

3

1 reference

19 September 2017

Lu YR

4

1 reference

19 September 2017

Ning QZ

5

1 reference

19 September 2017

Wang Q

6

1 reference

19 September 2017

publication date

1 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

67

1 reference

19 September 2017

issue

5

1 reference

19 September 2017

page(s)

368-376

1 reference

Dendritic cells: specialized and regulated antigen processing machines

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

In vitro induction of tumor-specific HLA class I-restricted CD8+ cytotoxic T lymphocytes from patients with locally advanced breast cancer by tumor antigen-pulsed autologous dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Tumor immunity meets autoimmunity: antigen levels and dendritic cell maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Dendritic cell-tumor fusion vaccines for renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Altered maturation of peripheral blood dendritic cells in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Immune effects and mechanisms of action of CpG motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte respons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Dendritic cell dysfunction in cancer: a mechanism for immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

MHC Class II Expression Is Regulated in Dendritic Cells Independently of Invariant Chain Degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Transient exposure of dendritic cells to maturation stimuli is sufficient to induce complete phenotypic maturation while preserving their capacity to respond to subsequent restimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Designer cancer vaccines are still in fashion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Dramatic increase of telomerase activity during dendritic cell differentiation and maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Enhanced Dendritic Cell Maturation by TNF- or Cytidine-Phosphate-Guanosine DNA Drives T Cell Activation In Vitro and Therapeutic Anti-Tumor Immune Responses In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Paucity of dendritic cells in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Distinct and overlapping roles of interleukin-10 and CD25+ regulatory T cells in the inhibition of antitumor CD8 T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

Immature dendritic cell/tumor cell fusions induce potent antitumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00590.X

10.1111/J.1399-0039.2006.00590.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference